ENHANCED IMMUNE RECONSTITUTION BY INTERLEUKIN-7 (IL-7) ADMINISTRATION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION IN MURINE MODELS Alpdogan, O.; Schmaltz, C.; Muriglan, S.J.; Kappel, B.J.; Rotolo, J.; van den Brink, M.TRANSPLANTED GENE-MARKED MARROW MESENCHYMAL CELLS ENGRAFT AND BENEFIT CHILDREN WITH SEVERE OSTEOGENESIS IMPERFECTA: A PILOT TRIAL FOR MARROW CELL THERAPY OF MESENCHYMAL DISORDERS Horwitz, E.M. ; Gordon, P.L.; Koo, W.K.; Neel, M.D.; Brown, P.S.; Marx, J.C.; Hofmann,T.J.MONITORING THE 'CYTOKINE STORM' ASPECT OF ACUTE GVHD BY MONOCYTE I.C. FLOW CYTOMETRY: POSITIVE CORRELATION WITH GVHD ONSET, SEVERITY, AND RESPONSE TO THERAPY Foley, J.E.; Leitzau, J.; Castro, K.; Kasten-Sportes, C.; Bishop,M.R.; Fowler,D.H.CO-ADMINISTRATION OF DONOR LYMPHOCYTE INFUSIONS (DLI) AND TUMOR VACCINES LEADS TO POTENT GVT EFFECT AGAINST METASTATIC BREAST AND COLON CANCER AND INDUCES ANTIGEN-SPECIFIC T CELLS Luznik, L.; Jill, S.E.; Ivan, B.; Hyam, L.; Drew, P.M.; Ephraim, F.J.BONE MARROW TRANSPLANTATION (BMT) FOR SICKLE CELL DISEASE (SCD): UPDATED RESULTS OF A MULTICENTER INVESTIGATION Walters, M.C.; Patience, M.; Leisenring, W.; Storb, R.; Sullivan, K.M.